Profit From Market Misconception (OMG! ImmunityBio Is Raining Gold!)
Dear Esteemed Investors,
I know you enjoyed my blog like this?one KISS?(Keep It Simple Stupid) as a strategy for Biotech Success.?
As such, I'll continue to share more.
You like the blog.?
I also run my own small business that I need to do the marketing myself.
Else, no one is going to do it for me.
But as you know, I don't bullshit you.
And, you can learn important biotech investing/trading principles from these blogs.
That mentioned, do you know this stock??ImmunityBio (IBRX)
It's such a wild and highly volatile biotech stock.
If you do not study its trading and fundamentals, you can lose a lot of money.
However, if you know this stock well (and more importantly, you know the prevailing market misconception), you can bank HUGE gains.
I'm not going to share with you the usual stuff:
"If you don't know me, I'm Dr. Harvey Tran, Founder/CEO of the private biotech investment group,?Integrated BioSci Investing:?The #1 Biotech Service for Growth Investing and Power Catalysts Trading
As a physician-scientist, I eat, breathe, and live biotech, which gives me?an EDGE?in biotech investing/trading. And, I'm super excited in bringing that advantage to assist and serve you."
You heard enough of that shit and saw enough of the Rolls Royces/Yatch picture.?
I ran out of it.?
If you know some other ideas for marketing, you let me know.
In this article, I'll show you how you can profit BIG from the market misconception with our catalysts biotech stocks.
The great thing about biotech is that you usually don't have to wait years.
Whenever there is a pending catalyst, the stock usually moves.?
Now, it could move in either direction depending on the expected and actual outcome of the catalyst.?
Our Founding Father (Abraham Lincoln) will tell you that "All men are created equal."?
However, the same is not true for biotech catalysts.
It's foolish to think that biotech catalysts are created equal.
But the media will keep feeding you that nonsense which causes you to lose money in biotech.
As you can see, a binary catalyst is the most important one for biotech.
As a "make or break" development, they're either an unprecedented FDA approval or a pending BIG data release of the crown jewel.
Those events will move your biotech stock BIG time.
From March 17 to May 8, you can see that ImmunityBio added 354.6% gains.?
Such a huge run-up is due to the market expectation of an upcoming/unprecedented approval of Anktiva for bladder cancer.
As he follows our community discussion/communal analysis closely, our stellar member (Dr. Jackye) who recommended ImmunityBio took partial profits before the crash.
In our community, we'd like to take partial profits (says, 1/2 of a full position on a stock that is flying high).?
That way, we protect our profits while riding further upside with the house's money.
As it turned out, the FDA-issued CRL (i.e., non-approval) caused the stock to crash over 50% in one day.
领英推荐
That day, the market traded with a misconception that there is no chance of approval and that most value is lost.
Nonetheless, our community knew better that the manufacturing issue as stated in the CRL can be easily ameliorated.?
Hence, our members forecasted the approval and our members started to build shares.
Two days ago (i.e., Sunday), we held our 7th Open-Mic Webinar (the first for a biotech private investment group) where we discussed ImmunityBio's comeback.
Monday, the stock started to trade aggressively higher.
As the market realized its misconception about the CRL, the stock?closed the day up by 44.9%.
Now, there is an even BIGGER catalyst for ImmunityBio that is being brewed.
And yet, the market overlooked it.
We also discussed it during the Open-Mic Webinar.?
Earlier today, I shared about it again in an?in-depth research?for our members.
If you're thinking about investing or trading ImmunityBio, you definitely don't want to miss out on that one.
Beyond our recent wins like Reata Pharmaceuticals (RETA), Madrigal Pharmaceuticals (MDGL), TG Therapeutics (TGTX), or Viking Therapeutics (VKTX) ...
There are just so much more catalysts and companies we're evaluating inside IBI.
Due to the huge number of physicians and non-doc experts that recently joined IBI, they're bringing many GREAT plays to our Private Investing Group.
Our legacy members also bring us great stocks.
If you lost some prior grounds, ImmunityBio and other stocks brewing that we shared inside IBI for members can help you regain it.
If you were a former IBI member (and I failed you in the past), give IBI a second chance.
I made mistakes in the past. But I've learned from it and I hope to have a chance to assist and serve you.
See the changes in our community for yourself.
When our members call the shots (and I as your assistant in doing the leg-work), things work out much better.
As usual, remember to spread out your trades to several stocks with pending catalysts.
That way, when some flop you'd still enjoy an overall winning record.
See what our members are saying ... There's?much more here?since 2017.
As such, we're offering you our?no-obligation 2-week FREE trial?to begin your biotech winning process.
To your success,
Harvey Tran, MD
Analyst's Disclosure:?I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours.
As a medical doctor/market expert, I'm not a registered investment advisor. Despite that I strive to provide the most accurate information, I neither guarantee the accuracy nor timeliness. Past performance does NOT guarantee future results. I reserve the right to make any investment decision for myself and my affiliates pertaining to any security without notification except where it is required by law. I'm also NOT responsible for the action of my affiliates. The thesis that I presented may change anytime due to the changing nature of information itself. Investing in stocks and options can result in a loss of capital. The information presented should NOT be construed as recommendations to buy or sell any form of security. My articles are best utilized as educational and informational materials to assist investors in your own due diligence process. That said, you are expected to perform your own due diligence and take responsibility for your action. You should also consult with your own financial advisor for specific guidance, as financial circumstances are individualized. That aside, I'm not giving you professional medical advice. Before embarking on any health-changing behavior, make sure you consult with your own doctor.
Seeking Alpha's Disclosure:?Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.